(Q44519483)

3 December 2017

title

A transgenic mouse model of the ubiquitin/proteasome system (English)

1 reference

ubiquitin-proteasome system

3 December 2017

main subject

0 references

author

Maria Masucci

series ordinal

3

1 reference

3 December 2017

4

1 reference

3 December 2017

Victoria Menéndez-Benito

object named as

Victoria Menéndez-Benito

series ordinal

2

0 references

author name string

Kristina Lindsten

series ordinal

1

1 reference

3 December 2017

publication date

20 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

21

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

897-902

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt851

3 December 2017

exact match

0 references

cites work

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

1 reference

7 January 2021

Regulation of the G1 to S transition by the ubiquitin pathway

1 reference

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

7 January 2021

The proteasome: paradigm of a self-compartmentalizing protease

1 reference

7 January 2021

1 reference

7 January 2021

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

7 January 2021

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

1 reference

7 January 2021

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

1 reference

7 January 2021

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation

1 reference

7 January 2021

Parkin and Parkinson's disease

1 reference

7 January 2021

Conformational disease

1 reference

7 January 2021

Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?

1 reference

7 January 2021

Protein misfolding and disease; protein refolding and therapy

1 reference

7 January 2021

Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.

1 reference

7 January 2021

Intranuclear inclusions and the ubiquitin-proteasome pathway: digestion of a red herring?

1 reference

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

7 January 2021

A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

1 reference

7 January 2021

Regulation and function of the p53 tumor suppressor protein

1 reference

7 January 2021

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

1 reference

7 January 2021

Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma

1 reference

7 January 2021

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

1 reference

7 January 2021

A proteasome inhibitor effectively prevents mouse heart allograft rejection

1 reference

7 January 2021

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

7 January 2021

Lessons from animal models of Huntington's disease

1 reference

7 January 2021

Genetically engineered mouse models of neurodegenerative diseases

1 reference

7 January 2021

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

1 reference

7 January 2021

A proteolytic pathway that recognizes ubiquitin as a degradation signal

1 reference

7 January 2021

'Green mice' as a source of ubiquitous green cells.

1 reference

7 January 2021

Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.

1 reference

7 January 2021

Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism

1 reference

7 January 2021

Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors

1 reference

7 January 2021

Proteasome inhibitors: from research tools to drug candidates

1 reference

7 January 2021

Lack of proteasome active site allostery as revealed by subunit-specific inhibitors

1 reference

7 January 2021

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

1 reference

7 January 2021

Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats

1 reference

7 January 2021

Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?

1 reference

7 January 2021

Monitoring the ubiquitin/proteasome system in conformational diseases

1 reference

7 January 2021

Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin

1 reference

7 January 2021

Mallory bodies revisited

1 reference

7 January 2021

Proteasome activation as a critical event of thymocyte apoptosis

1 reference

7 January 2021

Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli

1 reference

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

7 January 2021

Identifiers

DOI

10.1038/NBT851

1 reference

3 December 2017

1 reference